Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
A3787 Salirasib2 CitationSummary: Inhibitor of active Ras protein
-
A3826 SMIP004Summary: Apoptosis inducer
-
A3847 SU5416Target: VEGFRSummary: VEGF receptor inhibitor and AHR agonist
-
A3886 TrabectedinSummary: Antitumour agent
-
A3891 Triptolide1 CitationSummary: IL-2/MMP-3/MMP7/MMP19 inhibitor
-
A3935 WEHI-53915 CitationTarget: Bcl-xlSummary: Bcl-xL inhibitor,potent and selective
-
A3947 YM-155 hydrochlorideSummary: Potent survivin inhibitor
-
A4419 Ac-LEHD-AFCSummary: Fluorogenic caspase substrate
-
A4188 2-Methoxyestradiol (2-MeOE2)2 CitationSummary: Apoptotic, antiproliferative and antiangiogenic agent
-
A4116 Danusertib (PHA-739358)2 CitationTarget: Aurora KinasesSummary: Pan-aurora kinase inhibitor